It is reported that serum levels of two important adhesion molecules, ICAM1 and VCAM1 are significant higher in patients with colorectal cancer, ovarian cancer, NSCLC and breast cancer [25–28]. This evidence concerns the gene ICAM1 and non-small cell lung carcinoma.